Advent Access (Advent), one of Singapore’s most innovative medtech companies, has announced that it has been selec...
A new survey conducted by Johnson & Johnson Vision has revealed that a majority of Singaporeans (70%) and Thais (77%...
Researchers at Duke-NUS Medical School and their colleagues have identified a surprising interaction between dengue and ...
The substantial majority of women in Singapore are failing to undertake critical cancer screening tests, according to a ...
Smartfuture has recently announced the latest features to the Medcheck App - Teleconsultation and Marketplace. With thes...
OMRON HEALTHCARE Co., Ltd. and iAPPS Pte. Ltd. have announced the establishment of HeartVoice Pte. Ltd., a joint venture...
Tessa Therapeutics, a clinical-stage immunotherapy company focused on autologous and off-the-shelf, allogeneic therapies...
Singapore Cancer Society (SCS) and the National Cancer Centre Singapore (NCCS) have inked a partnership that will provid...
ASLAN Pharmaceuticals, a clinical-stage oncology-focused biopharmaceutical company developing novel therapeutics for glo...
The Singapore University of Social Sciences (SUSS) signed two Memoranda of Understanding (MOUs) to collab...
The spotlight was cast on the elderly and their caregivers as the Mitsui Sumitomo Insurance Welfare Foundation (“M...
Doctor Anywhere, a tech-led healthcare company, has launched Marketplace, an in-app e-commerce platform specially curate...
Sigal Atzmon, CEO of global medical case management company Medix, applauded the government's ‘Merdeka Generation ...
Researchers at Duke-NUS Medical School, Singapore have demonstrated for the first time that different sleep schedules wi...
Hummingbird Bioscience, a systems-biology enabled biotech company focused on the discovery and development of cancer the...
A NEW breast cancer drug shown to significantly reduce the risk of cancer recurrence is being made available to women in...
Immunotherapy drugs such as PD-L1 checkpoint inhibitors represent the front-line treatment for kidney cancer. But immuno...
Scientists from A*STAR’s Institute of Molecular and Cell Biology (IMCB) have discovered that niclosamide, an FDA-a...
